IP Library Granted Patent US 7,943,340
Granted Patent B2
US 7,943,340 · App. 12/217,470 · Granted May 17, 2011

Fungal dipeptidyl peptidase IV (DPPIV) enzyme for reagent use

Assignee: Funzyme Biotechnologies SA
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,943,340
App. No.
12/217,470
Granted
May 17, 2011
Kind
B2
Abstract

Disclosed herein are fungal nucleic acid sequences that encode novel dipetidyl peptidase IV (DPPIV) polypeptides. Also disclosed are polypeptides encoded by these nucleic acid sequences, as well as derivatives, variants, mutants, or fragments of the aforementioned polypeptide, polynucleotide, or antibody. The aminopeptidase polypeptides, referred to herein as DPPIV proteins of the invention are useful in a variety of medical, research, and commercial applications.

Claims (20)

1. A method for removing an aminoterminal Xaa-Pro tag from a protein, wherein Xaa is any amino acid, comprising the steps of:

(1) purification of the protein by covalent capture, and,

(2) contacting the protein with a polypeptide comprising an amino acid sequence which is at least 95% identical to SEQ ID NO: 35, or a fragment thereof, wherein said polypeptide or fragment has dipeptidyl peptidase IV activity, wherein the DPPIV activity consists of cleavage of the aminoterminal Xaa-Pro tag of the protein such that the aminoterminal Xaa-Pro is removed.

2. The method of claim 1 , wherein Xaa is an amino acid comprising at least two vicinal nucleophilic groups.

3. The method of claim 2 , wherein said amino acid is selected from the group consisting of serine, threonine and cysteine.

4. The method of claim 1 , wherein the polypeptide comprises the amino acid sequence set forth in SEQ ID NO: 35.

5. The method of claim 1 , wherein the polypeptide consists of the amino acid sequence set forth in SEQ ID NO: 35.

6. The method of claim 1 , wherein the polypeptide comprises an amino acid sequence comprising conservative amino acid substitutions of less than 5% of the amino acid residues of SEQ ID NO: 35.

7. The method of claim 3 , wherein the polypeptide comprises the amino acid sequence set forth in SEQ ID NO: 35.

8. The method of claim 3 , wherein the polypeptide consists of the amino acid sequence set forth in SEQ ID NO: 35.

9. The method of claim 3 , wherein the polypeptide comprises an amino acid sequence comprising conservative amino acid substitutions of less than 5% of the amino acid residues of SEQ ID NO: 35.

10. A method of removing the amino terminus from a protein wherein the amino terminus consists of an aminoterminal Xaa-Pro tag, wherein Xaa is any amino acid, said method comprising contacting the protein with polypeptide comprising an amino acid sequence which is at least 95% identical to SEQ ID NO: 35, or a fragment thereof, wherein said polypeptide or fragment has dipeptidyl peptidase IV (DPPIV) activity, wherein said DPPIV activity consists of cleaveage of the aminoterminal Xaa-Pro tag, such that the amino terminus of the protein is removed.

11. The method of claim 10 , wherein Xaa is an amino acid comprising at least two vicinal nucleophilic groups.

12. The method of claim 11 , wherein said amino acid is selected from the group consisting of serine, threonine and cysteine.

13. The method of claim 10 , wherein the DPPIV polypeptide comprises the amino acid sequence set forth in SEQ ID NO: 35.

14. The method of claim 10 , wherein the polypeptide consists of the amino acid sequence set forth in SEQ ID NO: 35.

15. The method of claim 10 , wherein the polypeptide comprises an amino acid sequence comprising conservative amino acid substitutions of less than 5% of the amino acid residues of SEQ ID NO: 35.

16. The method of claim 12 , wherein the polypeptide comprises the amino acid sequence set forth in SEQ ID NO: 35.

17. The method of claim 12 ,wherein the polypeptide consists of the amino acid sequence set forth in SEQ ID NO: 35.

18. The method of claim 12 , wherein the polypeptide comprises an amino acid sequence comprising conservative amino acid substitutions of less than 5% of the amino acid residues of SEQ ID NO: 35.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 27, 2015
From: FUNZYME BIOTECHNOLOGIES SA
To: AMYRA BIOTECH AG
Reel/Frame 036441/0685 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 11, 2011
From: MONOD, MICHEL; STOCKLIN, RETO; GROUZMANN, ERIC
To: ATHERIS LABORATORIES
Reel/Frame 025794/0161 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 11, 2011
From: ATHERIS LABORATORIES
To: FUNZYME BIOTECHNOLOGIES SA
Reel/Frame 025794/0255 →
Continuity (3)
Division 10569908
Provisional Application 60498318 · Aug 25, 2003
Related Publication 20090130737A1 · May 21, 2009